Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01261299
Recruitment Status : Terminated (Contract ended)
First Posted : December 16, 2010
Last Update Posted : January 9, 2018
Lawrence Livermore National Laboratory
National Institutes of Health (NIH)
Information provided by (Responsible Party):
University of California, Davis

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : November 2016
  Actual Study Completion Date : November 2016